IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
WRNIP1 | Werner helicase interacting protein 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
NQO2 | NAD(P)H dehydrogenase, quinone 2 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
RIPK1 | Receptor (TNFRSF)-interacting serine-threonine kinase 1 | Enzymes
| | | | | Expressed in all |
ECI2 | Enoyl-CoA delta isomerase 2 | Enzymes
| | | | | Expressed in all |
CDYL | Chromodomain protein, Y-like | Enzymes
| | | | | Expressed in all |
LYRM4 | LYR motif containing 4 | Disease related genes
| | | | | Expressed in all |
F13A1 | Coagulation factor XIII, A1 polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
SSR1 | Signal sequence receptor, alpha | Predicted membrane proteins
| | | | | Expressed in all |
DSP | Desmoplakin | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | Disease related genes Transcription factors
| | | | | Tissue enhanced |
PAK1IP1 | PAK1 interacting protein 1 | | | | | | Expressed in all |
SIRT5 | Sirtuin 5 | FDA approved drug targets
| | | | | Expressed in all |
NOL7 | Nucleolar protein 7, 27kDa | | | | | | Expressed in all |
DTNBP1 | Dystrobrevin binding protein 1 | Disease related genes
| | | | | Expressed in all |
NUP153 | Nucleoporin 153kDa | | | | | | Expressed in all |
DEK | DEK oncogene | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
GMNN | Geminin, DNA replication inhibitor | Cancer-related genes
| | | | | Expressed in all |
LRRC16A | Leucine rich repeat containing 16A | | | | | | Mixed |
SCGN | Secretagogin, EF-hand calcium binding protein | Plasma proteins
| | | | | Tissue enhanced |
HIST1H3B | Histone cluster 1, H3b | Cancer-related genes
| | | | | Tissue enriched |
HIST1H2AB | Histone cluster 1, H2ab | | | | | | Tissue enhanced |
HIST1H1C | Histone cluster 1, H1c | Plasma proteins
| | | | | Expressed in all |
HIST1H2AE | Histone cluster 1, H2ae | | | | | | Tissue enhanced |
BTN3A3 | Butyrophilin, subfamily 3, member A3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ZNF322 | Zinc finger protein 322 | Transcription factors
| | | | | Mixed |
HIST1H3H | Histone cluster 1, H3h | | | | | | Tissue enhanced |
TRIM26 | Tripartite motif containing 26 | | | | | | Expressed in all |
PPP1R10 | Protein phosphatase 1, regulatory subunit 10 | | | | | | Expressed in all |
MRPS18B | Mitochondrial ribosomal protein S18B | Mitochondrial proteins Ribosomal proteins
| | | | | Expressed in all |
DHX16 | DEAH (Asp-Glu-Ala-His) box polypeptide 16 | Enzymes
| | | | | Expressed in all |
MDC1 | Mediator of DNA-damage checkpoint 1 | Cancer-related genes
| | | | | Expressed in all |
POU5F1 | POU class 5 homeobox 1 | Cancer-related genes Transcription factors
| | | | | Mixed |
DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | Enzymes Plasma proteins Transporters
| | | | | Expressed in all |
BAG6 | BCL2-associated athanogene 6 | | | | | | Expressed in all |
CLIC1 | Chloride intracellular channel 1 | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |
VARS | Valyl-tRNA synthetase | Enzymes Plasma proteins
| | | | | Expressed in all |
HSPA1A | Heat shock 70kDa protein 1A | Cancer-related genes Mitochondrial proteins Plasma proteins Transporters
| | | | | Expressed in all |
EHMT2 | Euchromatic histone-lysine N-methyltransferase 2 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
PSMB9 | Proteasome (prosome, macropain) subunit, beta type, 9 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
BRD2 | Bromodomain containing 2 | | | | | | Expressed in all |
DAXX | Death-domain associated protein | Cancer-related genes
| | | | | Expressed in all |
LEMD2 | LEM domain containing 2 | Predicted membrane proteins
| | | | | Expressed in all |
RPS10 | Ribosomal protein S10 | Disease related genes Plasma proteins Ribosomal proteins
| | | | | Expressed in all |
SNRPC | Small nuclear ribonucleoprotein polypeptide C | Plasma proteins
| | | | | Expressed in all |
FANCE | Fanconi anemia, complementation group E | Cancer-related genes Disease related genes Plasma proteins
| | | | | Mixed |
FKBP5 | FK506 binding protein 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
SRSF3 | Serine/arginine-rich splicing factor 3 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CMTR1 | Cap methyltransferase 1 | Enzymes
| | | | | Expressed in all |